Project Grant R43DA063467
Award Date
8/1/25
Completion Date
1/31/26
Dollars Obligated
$305K
Federal Agency
National Institute on Drug Abuse
Awardee
Taesun, LLC (PC58X2UHL3N4)
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Colorado, USA
Similar Awards
The National Institute on Drug Abuse (NIDA) awarded Instanosis Inc., a woman-owned small business in Pennsylvania, a $1,576,513 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a rapid, sensitive, and instrument-free oral fluid fentanyl test. This project aims to create the first FDA-cleared oral fluid fentanyl rapid test that is 10 times more sensitive, has a 5-minute readout time (4 times faster), and requires 100 mL of oral fluid (10 times less volume)...
This Project Grant award from the National Institute of Justice (CFDA 16.560 - National Institute of Justice Research, Evaluation, and Development Project Grants) provides $434,500 to 9 Delta Analytical, LLC to develop two key products: 1) An inexpensive, visually-read testing device that allows rapid identification of fentanyl and other opioids in oral fluid samples, and 2) Environmentally-friendly laboratory confirmation procedures for analyzing the same oral fluid samples. The goal is to...
The National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), awarded Labsys LLC a $643,948 Project Grant to develop a wearable continuous drug monitoring device for opioid use disorders (CDM-MOUD). The goal is to create a low-cost, pain-free patch that can monitor medication levels in the interstitial fluid and provide real-time insights into the effectiveness of opioid use disorder treatment protocols. In Phase I, Labsys will engineer an...
This $586,936 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a low-cost, disposable urine test strip that can rapidly and quantitatively measure substance use disorder (SUD) medication drugs and their metabolites. The award recipient, Vitan-Biotech LLC, will create a point-of-use lateral flow assay (LFA) test strip that leverages innovative signal amplification technology to...
The National Institute on Drug Abuse (NIDA) awarded a $386,452 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to Electronic Biosciences, Inc., a small biotechnology company in San Diego, California. The grant supports the development of a rapid fingerstick diagnostic test for opioid and stimulant use disorders. This project aims to address the escalating public health crisis of opioid and stimulant overdose deaths in the United States, which reached over 107,000 in...
The National Institute on Drug Abuse (NIDA) awarded Resilient Lifescience, Inc. a $854,122 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a wearable medical device that can detect opioid-induced respiratory depression and issue an emergency alert. The goal is to create a technology solution that can help ensure rapid administration of the life-saving drug naloxone when an opioid overdose occurs, particularly in situations where the individual is...
This federal Project Grant award from the National Institute of Justice (CFDA 16.560 - National Institute of Justice Research, Evaluation, and Development Project Grants) provides $308,002 to Oakland University to develop an affordable, portable electrochemical sensor device for rapid, accurate detection of fentanyl and other opioids. The key objectives are to: 1) Fabricate a needle-based sensor, 2) Optimize the electrochemical signal analysis and detection for fentanyl, and 3) Test and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $399,536 to Chemregen Inc.'s Human Biomolecular Research Institute in San Diego, CA. The funding supports research to design, synthesize, and test non-opioid drug candidates as potential treatments for opioid use disorder and fentanyl toxicity. Key objectives include characterizing the effects of opioids on human induced pluripotent stem...
The National Institute on Drug Abuse (NIDA) awarded a $1,539,426 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to Serodopa Therapeutics Inc. to develop a novel intranasal formulation of a naloxone derivative for the reversal of opioid-induced respiratory depression caused by high-potency opioids such as fentanyl. The project aims to complete formulation development, preclinical toxicology and safety testing required to prepare an Investigational New Drug (IND)...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is supporting the development of a software-based medical device (SAMD) for detecting opioid use through voice analysis. The $800,000 award to Tenvos Inc., a minority-owned and woman-owned technology company, aims to advance the company's AI-driven solution that can enable patients to remotely test for opioid use and securely share results with...